Notice of Results & Presentations

Diaceutics PLC

01 May 2024

 

Diaceutics - Notice of Results & Presentations

Belfast and London, 1 May 2024 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, will announce its audited final results for the year ended 31 December 2023 on Tuesday, 21 May 2024.

Analyst Presentation

A webinar presentation for investors and analysts will be held at 1330 BST (0830 ET) on Tuesday, 21 May 2024. Those wishing to attend can register using the following link:

https://stifel.zoom.us/webinar/register/WN_avvLvNSEQ-GNugz8dbboZg

Investor Meet Presentation

A webinar presentation for investors will be held via the Investor Meet platform at 1630 BST (1130 ET) on Tuesday, 21 May 2024. The presentation is open to all existing and potential shareholders and registration can be completed via the following link:

https://www.investormeetcompany.com/diaceutics-plc/register-investor

Questions can be submitted pre-event via your Investor Meet Company dashboard up until 0900 (BST) the day before the meeting or at any time during the live presentation. Investors who already follow Diaceutics on the Investor Meet Company platform will automatically be invited.

Enquiries: 

Diaceutics PLC
Ryan Keeling, Chief Executive Officer   Nick Roberts, Chief Financial Officer	Tel: [phone] [e-mail]
Stifel Nicolaus Europe Limited (Nomad & Broker)	Tel: [phone]
Ben Maddison
Nick Harland
Kate Hanshaw
Alma Strategic Communications	Tel: [phone]
Caroline Forde Kinvara Verdon Kieran Breheny	[e-mail]

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.

We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network ®.

 

END